| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/16/2014 | US20140018365 Pharmaceutically active compounds as axl inhibitors |
| 01/15/2014 | EP2683690A1 Quinolinone derivatives |
| 01/15/2014 | CN103517896A Quinolinone derivatives |
| 01/15/2014 | CN103508960A Benzoheterocyclic derivatives |
| 01/15/2014 | CN103508950A 4-hydroxy-2-quinolinone compounds containing imine structure, and preparation and application thereof |
| 01/15/2014 | CN103508949A Synthetic method of (E)-3-[2-cyclopropyl-4-(4-fluorine-phenyl)-3-quinolyl) acrolein |
| 01/15/2014 | CN103508948A Method for preparing pitavastatin calcium |
| 01/15/2014 | CN103508947A Preparation method of pitavastatin calcium |
| 01/15/2014 | CN103508946A Preparation method of pitavastatin calcium |
| 01/15/2014 | CN103508940A 6, 6-disubstituted-6-H-benzo[cd]pyrene derivatives and intermediates, and preparation methods and applications of derivatives and intermediates |
| 01/15/2014 | CN103508930A Bis(aminodithioformate)-1,3-propane diester compound, and synthesis method, pharmaceutical composition and use thereof |
| 01/14/2014 | US8628863 Indenopyrene compound and organic light-emitting device using the compound |
| 01/14/2014 | CA2650798C Inhibitors of human immunodeficiency virus replication |
| 01/14/2014 | CA2528849C Quinoline derivatives as antibacterial agents |
| 01/09/2014 | WO2014008214A1 Biaryl-containing compounds as inverse agonists of ror-gamma receptors |
| 01/09/2014 | WO2014005968A1 Novel adamantyl derivatives as cannabinoid receptor 2 agonists |
| 01/09/2014 | US20140012004 New palladium catalyst, method for its preparation and its use |
| 01/09/2014 | US20140012003 Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| 01/09/2014 | CA2876443A1 Novel adamantyl derivatives as cannabinoid receptor 2 agonists |
| 01/08/2014 | EP2682383A1 Auxin biosynthesis inhibitor |
| 01/08/2014 | EP2681198A1 Novel small-molecules as therapeutics |
| 01/08/2014 | CN103502219A Novel small-molecules as therapeutics |
| 01/08/2014 | CN103502217A Diarylacetylene hydrazide containing tyrosine kinase inhibitors |
| 01/08/2014 | CN103502204A Auxin biosynthesis inhibitor |
| 01/08/2014 | CN103497114A NMDA receptor antagonists for neuroprotection |
| 01/07/2014 | US8623893 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof |
| 01/03/2014 | WO2014003424A1 Novel rebamipide prodrug, method for producing same, and usage thereof |
| 01/03/2014 | WO2014001860A1 Process for preparation of montelukast sodium |
| 01/03/2014 | WO2014001247A1 N-[4-(Quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| 01/03/2014 | WO2014000694A1 Phendioxin heterocycle derivative |
| 01/03/2014 | CA2877786A1 N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products |
| 01/03/2014 | CA2875461A1 3-o-heteroaryl-ingenol |
| 01/02/2014 | US20140005402 Crystalline forms of pitavastatin calcium |
| 01/02/2014 | US20140005401 Process for Preparing Quinoline-3-Carboxamide Derivatives |
| 01/02/2014 | US20140005186 Androgen receptor modulator compounds and methods |
| 01/02/2014 | US20140005178 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/01/2014 | EP2678316A2 Substituted aromatic sulfur compounds and methods of their use |
| 01/01/2014 | CN203370555U Continuous alkali fusion device |
| 01/01/2014 | CN103492363A Polymerizable compound, polymerizable composition, polymer, and optically anisotropic material |
| 01/01/2014 | CN103492028A Novel sulfonaminoquinoline hepcidin antagonists |
| 01/01/2014 | CN103483254A Method for synthesizing 3-methylquinoline-8-sulfonyl chloride |
| 01/01/2014 | CN103483253A Synthesis method of 8-hydroxyquinaldine |
| 01/01/2014 | CN103483252A Synthetic method of 2-cyclopropyl-4-(4-fluorophenyl)-3-quinolylmethanol |
| 01/01/2014 | CN103483251A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 01/01/2014 | CN101252927B Quinoline derivatives as antibacterial agents |
| 12/31/2013 | US8618302 Methods and compositions of targeted drug development |
| 12/31/2013 | US8618296 Arylethynyl derivatives |
| 12/31/2013 | US8618132 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
| 12/31/2013 | US8618131 Biphenyl derivatives |
| 12/31/2013 | US8618122 Compound having acidic group which may be protected, and use thereof |
| 12/31/2013 | CA2705318C Inhibitors of human immunodeficiency virus replication |
| 12/31/2013 | CA2552565C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 12/27/2013 | WO2013157889A9 Use of a novel aminopyridine derivative to prevent or treat cancer |
| 12/26/2013 | US20130345429 Process and intermediate compounds useful in the preparation of statins |
| 12/26/2013 | US20130345256 N-ethyl-4-hydroxyl-1-methyl-5-(methyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide |
| 12/26/2013 | US20130345212 Quinolinone derivatives |
| 12/25/2013 | EP2675790A1 Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of alzheimer's disease |
| 12/25/2013 | EP2675526A1 Novel sulfonaminoquinoline hepcidin antagonists |
| 12/25/2013 | EP2413190B1 Curable coloring composition, color filter and method for producing same, and quinophthalone dye |
| 12/25/2013 | EP2152670B1 Bridged six-membered ring compounds |
| 12/25/2013 | CN103476755A Compounds and methods |
| 12/25/2013 | CN103476754A Adamantyl compounds |
| 12/25/2013 | CN103476753A Novel rebamipide complexes and cocrystals |
| 12/25/2013 | CN103476752A Substituted aromatic sulfur compounds and methods of their use |
| 12/25/2013 | CN103476749A Alpha,beta-unsaturated imines |
| 12/25/2013 | CN103468238A Preparation method and application of novel high-efficient acidification corrosion inhibitor |
| 12/25/2013 | CN103467374A Synthesis method of 8-bromine-4-carboxyl quinoline |
| 12/25/2013 | CN103467373A Synthetic method of quinoline compounds |
| 12/25/2013 | CN103467372A Combined production method for antioxidant RD and antioxidant FR |
| 12/25/2013 | CN102702096B Quinoline nitrile derivative with aggregation-induced emission performance |
| 12/25/2013 | CN101525315B Chemical process for extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 12/24/2013 | US8614327 Modulators of ATP-binding cassette transporters |
| 12/24/2013 | US8614326 Therapeutic quinoline and naphthalene derivatives |
| 12/24/2013 | US8614325 Modulators of cystic fibrosis transmembrane conductance regulator |
| 12/24/2013 | US8614317 Sulfonamide derivatives of polycyclic dyes used for analytical applications |
| 12/24/2013 | US8614229 Substituted indole derivatives and methods of use thereof |
| 12/24/2013 | CA2714181C Ampk modulators |
| 12/19/2013 | US20130338151 Fused ring analogues of anti-fibrotic agents |
| 12/19/2013 | US20130338109 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 12/19/2013 | US20130338108 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 12/18/2013 | EP2673262A1 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds |
| 12/18/2013 | EP2496557B1 Tetrahydroquinoline derivatives and their pharmaceutical use |
| 12/18/2013 | CN103459373A Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds |
| 12/18/2013 | CN103450078A 2-aryl-6-(2-aryl acetylenyl) cinolineand and preparation method thereof |
| 12/18/2013 | CN103450077A IRE-1A inhibitors |
| 12/18/2013 | CN103449947A Pre-purification method before sublimation and purification of OLED (organic light emitting diode) material |
| 12/18/2013 | CN102757555B Dequalinium chloride-polyethylene glycol-distearoyl phosphatidyl ethanolamine conjugated compound and resveratrol liposome modified thereby |
| 12/17/2013 | US8609847 Dihydroquinolinone derivatives |
| 12/17/2013 | CA2611893C Tetrahydroquinolines for use as modulators of the mitotic motor protein eg5 |
| 12/12/2013 | US20130331568 Acetylene derivatives having mglur 5 antagonistic activity |
| 12/12/2013 | US20130331567 Modulators of atp-binding cassette transporters |
| 12/12/2013 | US20130331411 Compounds and methods for treating diseases mediated by protease activated receptors |
| 12/12/2013 | US20130330284 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof |
| 12/11/2013 | EP2670734A1 Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease |
| 12/11/2013 | CN103435544A 喹诺酮化合物 Quinolone compounds |
| 12/11/2013 | CN103435543A Preparation method of ChimDnine D |
| 12/11/2013 | CN103435542A 2-biaryl-6-arylquinazoline and preparation method thereof |
| 12/11/2013 | CN103435514A Matrix metalloproteinase inhibitor and purpose thereof |
| 12/11/2013 | CN102285917B Pitavastatin calcium compound and preparation method thereof |
| 12/11/2013 | CN102040591B 7-phenyl quinolone compounds |